Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Invested Capital (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Invested Capital for 6 consecutive years, with $89.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 21.1% year-over-year to $89.1 million, compared with a TTM value of $89.1 million through Dec 2025, down 21.1%, and an annual FY2025 reading of $89.1 million, down 21.1% over the prior year.
  • Invested Capital was $89.1 million for Q4 2025 at Treace Medical Concepts, roughly flat from $89.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $157.6 million in Q1 2023 and bottomed at $28.5 million in Q1 2021.
  • Average Invested Capital over 5 years is $101.2 million, with a median of $100.3 million recorded in 2021.
  • The sharpest move saw Invested Capital soared 130167.09% in 2021, then tumbled 36.12% in 2022.
  • Year by year, Invested Capital stood at $93.1 million in 2021, then tumbled by 34.97% to $60.5 million in 2022, then skyrocketed by 127.89% to $137.9 million in 2023, then decreased by 18.16% to $112.9 million in 2024, then dropped by 21.1% to $89.1 million in 2025.
  • Business Quant data shows Invested Capital for TMCI at $89.1 million in Q4 2025, $89.2 million in Q3 2025, and $97.6 million in Q2 2025.